The US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) for ...

KBRA assigns preliminary ratings to four classes of notes issued by Oportun Funding Trust 2025-1 ("Oportun 2025-1"), a $159.144 million consumer loan ABS transaction. Oportun 2025-1 is an amortizing ...

Twenty-five percent tariffs on Canada and Mexico will come into effect on Saturday, while China has been threatened with a 10 ...

In response to former US President Donald Trump's imposition of a 25 per cent tariff on Mexican imports, Mexico's President Claudia Sheinbaum has announced counter-tariffs on American goods, further ...

Rejecting allegations from the White House that her administration has ties to criminal organisations, Sheinbaum shifted the blame onto the US, accusing American arms dealers of supplying weapons to ...

Within less than a decade, Charles’s ‘reign of peace’ had imploded and the two amateur impresarios found themselves on opposing sides in the ensuing civil war – Bulstrode Whitelocke (1605–75) as a ...

Welireg's sNDA for advanced PPGL treatment is under FDA priority review ... “PPGL are rare tumors that form in and around the adrenal glands, and currently, there are no approved therapies available ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...